Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:33:23.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows a 500-style error page with an HTML structure indicating the requested study record is temporarily unavailable.
    Difference
    18%
    Check dated 2026-08-10T11:50:42.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a minor site update that does not alter the study information.
    Difference
    0.1%
    Check dated 2026-07-27T05:53:11.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3 in the footer, updating from v3.6.2 to v3.6.3. This indicates a maintenance/version update rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-05T11:16:30.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a small site update without changing the study details or related content.
    Difference
    0.1%
    Check dated 2026-06-28T08:17:54.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Added explicit recruitment status ('No longer looking for participants') and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Removed the 'Intervention / Treatment' heading and updated the revision label from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T03:27:39.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.